Zura Bio Ltd
ZURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855644
No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Zura Bio Ltd changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 36 | 33 | −3 |
| Shares | 7.88M | 8.43M | +542.1K (+6.9%) |
| Value | $77.7M | $84.2M | +$6.56M (+8.4%) |
New holders (3)
Institutions that held Zura Bio Ltd at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Westchester Capital Management, LLC | 254,044 | $2.55M | 0.08% |
| Vivaldi Asset Management, LLC | 118,750 | $1.19M | 0.06% |
| BNP Paribas Arbitrage, SA | 105,981 | $1.07M | 0.00% |
Sold out (6)
Institutions that held Zura Bio Ltd at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Bank of Montreal | 324,700 | $3.23M |
| Basso Capital Management, L.P. | 194,971 | $1.94M |
| Deutsche Bank AG | 46,756 | $465.0K |
| Meteora Capital, LLC | 18,206 | $181.0K |
| Old Mission Capital LLC | 18,065 | $180.0K |
| Cohen & Co Financial Management, LLC | 79,466 | $14.0K |